Fateen E - Search Results

1

Twenty- five years of biochemical diagnosis of Gaucher disease: the Egyptian experience.

Fateen E, Abdallah ZY. Fateen E, et al. Heliyon. 2019 Nov 1;5(10):e02574. doi: 10.1016/j.heliyon.2019.e02574. eCollection 2019 Oct. Heliyon. 2019. PMID: 31720445 Free PMC article.

2

Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt.

Fateen E, Abdallah ZY, Nazim WS, Ibrahim M, Radwan A. Fateen E, et al. Heliyon. 2021 Aug 19;7(8):e07830. doi: 10.1016/j.heliyon.2021.e07830. eCollection 2021 Aug. Heliyon. 2021. PMID: 34471711 Free PMC article.

3

Diagnosis and management of galactosemia: an Egyptian experience.

Fateen E, el-Shafei S, el-Karaksy H, Mahmoud M, Roshdy S, el-Temtamy S, Shin Y. Fateen E, et al. Bratisl Lek Listy. 2004;105(9):303-9. Bratisl Lek Listy. 2004. PMID: 15633891

4

Four novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase gene among Egyptian patients with Morquio A disease.

Fateen EM, El Mawgoud HA, Eissa NR, Ibrahim MM, Aglan MS, Essawi ML. Fateen EM, et al. Gene. 2017 Feb 5;600:48-54. doi: 10.1016/j.gene.2016.11.002. Epub 2016 Nov 5. Gene. 2017. PMID: 27825773

5

Clinical, Biochemical, and Molecular Characterization of Metachromatic Leukodystrophy Among Egyptian Pediatric Patients: Expansion of the ARSA Mutational Spectrum.

Amr K, Fateen E, Mansour L, Tosson AM, Zaki MS, Salam GMA, Mohamed AN, El-Bassyouni HT. Amr K, et al. Among authors: fateen e. J Mol Neurosci. 2021 May;71(5):1112-1130. doi: 10.1007/s12031-020-01734-1. Epub 2020 Nov 13. J Mol Neurosci. 2021. PMID: 33185815

6

Biochemical and mutational analyses of HEXA in a cohort of Egyptian patients with infantile Tay-Sachs disease. Expansion of the mutation spectrum.

Ibrahim DMA, Ali OSM, Nasr H, Fateen E, AbdelAleem A. Ibrahim DMA, et al. Among authors: fateen e. Orphanet J Rare Dis. 2023 Mar 13;18(1):52. doi: 10.1186/s13023-023-02637-1. Orphanet J Rare Dis. 2023. PMID: 36907859 Free PMC article.

7

Prenatal diagnosis of mucopolysaccharidoses (MPS): the first Egyptian experience.

Aboul Nasr A, Fateen E. Aboul Nasr A, et al. Among authors: fateen e. Bratisl Lek Listy. 2004;105(9):310-4. Bratisl Lek Listy. 2004. PMID: 15633892

8

Molecular characterization of Egyptian patients with glycogen storage disease type IIIa.

Endo Y, Fateen E, Aoyama Y, Horinishi A, Ebara T, Murase T, Shin YS, Okubo M. Endo Y, et al. Among authors: fateen e. J Hum Genet. 2005;50(10):538-542. doi: 10.1007/s10038-005-0291-3. Epub 2005 Sep 28. J Hum Genet. 2005. PMID: 16189622

9

A report of three patients with MMP2 associated hereditary osteolysis.

Temtamy SA, Ismail S, Aglan MS, Ashour AM, Hosny LA, El-Badry TH, Aboul-Ezz EH, Amr K, Fateen E, Maguire T, Ungerer K, Zankl A. Temtamy SA, et al. Among authors: fateen e. Genet Couns. 2012;23(2):175-84. Genet Couns. 2012. PMID: 22876575

10

Glycogen storage disease type III in Egyptian children: a single centre clinico-laboratory study.

El-Karaksy H, Anwar G, El-Raziky M, Mogahed E, Fateen E, Gouda A, El-Mougy F, El-Hennawy A. El-Karaksy H, et al. Among authors: fateen e. Arab J Gastroenterol. 2014 Jun;15(2):63-7. doi: 10.1016/j.ajg.2014.01.013. Epub 2014 Feb 12. Arab J Gastroenterol. 2014. PMID: 25097048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters